6th Cytokine-Based Drug Development Summit 2025

With more cytokine-based drugs entering clinical trials and novel combination and masking technologies being used, there is a growing need for experts to discuss, understand, and build on the current potential of cytokine-based drugs.

The 6th Cytokine-Based Drug Development Summit (May 15-16 in Boston) returns as the only industry focused conference that provides practical knowledge, reflective lessons and innovative approaches to support the community overcome the shared challenges within cytokine drug development.

Our comprehensive agenda includes two full days of presentations led by industry-leading experts. Take away valuable lessons, including:

Examining the Cytokine landscape from a global perspective to learn from the major failures and build from the successes across oncology, immunology, and inflammation with Beacon
Exploring how major toxicity challenges are being addressed with the use of next-generation masking technologies, pulsed cytokine deliveries, manipulating the immune system, and more with Candel, Regeneron, Sanofi, OSE, Werewolf, and Indaptus
Discovering how synthetic cytokine mimetics are engineered to improve cell bias and minimize toxicity while improving their properties for better manufacturability and scalability
Navigating through major animal model challenges as experts evaluate how to utilize existing models and improve their translation relevance for cytokine-based therapies with ModeX and Synthekine